🔎 Trials Near Me

Home › Melanoma › North Carolina

Pag-aaral pangklinika para sa Melanoma sa North Carolina

31 pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

  • Lineberger Comprehensive Cancer Center, Chapel Hill
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07740941

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Southeastern Medical Oncology Center-Clinton, Clinton
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • Messino Cancer Center, Asheville
  • Levine Cancer Institute, Charlotte
  • Novant Health Cancer Institute, Charlotte
  • at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06246916

Pan-tumor MRD Study

  • Carolina Oncology Specialists, Charlotte
  • Southeastern Medical Oncology Center (SMOC), Goldsboro
  • Regional Medical Oncology Center, Wilson
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Duke Cancer Center Cary, Cary
  • Duke University Medical Center, Durham
  • Duke Cancer Center Raleigh, Raleigh
Nagre-recruitPhase 3
Edad 75 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07068074

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Carolina Biooncology Institute, Huntersville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0100, Durham
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Wake Forest University at Clemmons, Clemmons
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • at 4 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • UNC- Chapel Hill, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

  • University of North Carolina, Chapel Hill
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288112

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AdventHealth Infusion Center Asheville, Asheville
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • AdventHealth Infusion Center Haywood, Clyde
  • at 6 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

Project: Every Child for Younger Patients With Cancer

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • at 4 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

  • Lineberger Comprehensive Cancer Center, Chapel Hill
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT03454035

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, Huntersville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Carolina Cancer Research Center, Wilson
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06270706

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT05077137

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

  • UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT03947385

IL-17 Blockade to Decrease irAEs (REPLAY)

  • Duke University Health System, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT07237594

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  • University of North Carolina at Chapel Hill, Chapel Hill
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Duke University Medical Center, Durham
Nagre-recruitPhase 2/3
Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Atrium Health Stanly/LCI-Albemarle, Albemarle
  • Cone Health MedCenter Asheboro, Asheboro
  • Cone Health Cancer Center at Alamance Regional, Burlington
  • at 21 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

  • Carolina BioOncology Institute, Huntersville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07317505

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • Duke University Medical Center - Duke Cancer Center, Durham
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

  • Duke University Health System, Durham
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2025 · NCT05839912

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University Medical Center, Durham
  • East Carolina University, Greenville
  • at 1 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 27, 2024 · NCT03860883

DermaSensor Postmarket Surveillance Study

  • West Clinical Research, Morehead City
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 31, 2024 · NCT06666790

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.